(FOLD)
Amicus Therapeutics Inc (FOLD) poses a Brand-New Opportunity for Investors with beta value of 0.65
Shaun Noe
Witnessing the stock’s movement on the chart, on Thursday, Amicus Therapeutics Inc (NASDAQ: FOLD) set off with pace as it ...
Amicus Therapeutics Inc (FOLD) is heading in the right direction with an average volume of $4.55M
Zack King
Witnessing the stock’s movement on the chart, on Thursday, Amicus Therapeutics Inc (NASDAQ: FOLD) set off with pace as it ...
